Risk Stratification of Newly Diagnosed Multiple Myeloma: Predictive Value of First‐Year Biomarker Trajectories Identified by Group‐Based Trajectory Modeling
Hexiang Bai,
Wenjiao Tang,
Yan Li,
Bing Xiang,
Kunlian Li,
Min Sun,
Yuhuan Zheng,
Li Zhang,
Ting Niu Cancer Medicine
· Wiley
· 2026-11-11
· DOI: 10.1002/cam4.72503
The publisher did not provide an abstract — full text is available via the link below.
Hexiang Bai, Wenjiao Tang, Yan Li, Bing Xiang, Kunlian Li, Min Sun et al. Risk Stratification of Newly Diagnosed Multiple Myeloma: Predictive Value of First‐Year Biomarker Trajectories Identified by Group‐Based Trajectory Modeling. // Cancer Medicine. – 2026. – DOI: 10.1002/cam4.72503. – URL: https://onlinelibrary.wiley.com/doi/10.1002/cam4.72503?af=R
Hexiang Bai, Wenjiao Tang, Yan Li, Bing Xiang, Kunlian Li, Min Sun, Yuhuan Zheng, Li Zhang, & Ting Niu (2026). Risk Stratification of Newly Diagnosed Multiple Myeloma: Predictive Value of First‐Year Biomarker Trajectories Identified by Group‐Based Trajectory Modeling. Cancer Medicine. https://doi.org/10.1002/cam4.72503
Hexiang Bai, et al. “Risk Stratification of Newly Diagnosed Multiple Myeloma: Predictive Value of First‐Year Biomarker Trajectories Identified by Group‐Based Trajectory Modeling.” Cancer Medicine, 2026. doi:10.1002/cam4.72503.
@article{Bai2026,
title = {Risk Stratification of Newly Diagnosed Multiple Myeloma: Predictive Value of First‐Year Biomarker Trajectories Identified by Group‐Based Trajectory Modeling},
author = {Bai, Hexiang and Tang, Wenjiao and Li, Yan and Xiang, Bing and Li, Kunlian and Sun, Min and Zheng, Yuhuan and Zhang, Li and Niu, Ting},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72503},
url = {https://onlinelibrary.wiley.com/doi/10.1002/cam4.72503?af=R}
}